Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-Small Cell Lung Cancer NSCLC × Fluorodeoxyglucose F18 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Oropharyngeal Neoplasms 1 Non-Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Carcinoma, Hepatocellular 1

Interventions

alfatide II 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06416852 2024-05-16

Clinical Study of 18F-Alfatide Injection PET/CT

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 3 Not yet recruiting

Non-Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡